US OptionsDetailed Quotes

QGEN250516C35000

Watchlist

5.40
0.000.00%

15min DelayTrading Apr 2 13:32 ET

0.00High0.00Low

Qiagen NV Stock Discussion

Teddy123

10 hours ago

QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase

$Qiagen NV (QGEN.US)$
QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase

Teddy123

Apr 23 12:24

QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025

$Qiagen NV (QGEN.US)$
QIAGEN Revolutionizes Cancer Research: New 700-Gene Profiling System Plus Major Partnerships Reshape Genomic Testing

Teddy123

Apr 7 05:49

QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook

$Qiagen NV (QGEN.US)$
QIAGEN Smashes Q1 Targets: 7% Growth Powers Confident 2025 Outlook Boost

Teddy123

Feb 6 09:48

QIAGEN delivers solid Q4 2024 growth ahead of outlook

$Qiagen NV (QGEN.US)$
QIAGEN Earnings Triumph: Key Products Surge, Margins Expand as Cash Flow Hits Record

Stock_Drift

Jan 13 06:46

$Qiagen NV (QGEN.US)$

Sean Parker

Jan 13 06:35

QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase

$Qiagen NV (QGEN.US)$

Sean Parker

Jan 10 16:59

QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples

$Qiagen NV (QGEN.US)$
QIAGEN (NYSE: QGEN) has announced significant enhancements to its QIAcuity Digital PCR system, enabling simultaneous analysis of up to 12 targets from a single biological sample, more than doubling its previous capability of five targets. This upgrade is achieved through the new QIAcuity Software 3.1 and the launch of the QIAcuity High Multiplex Probe PCR...

Lnova

Nov 18, 2024 05:34

QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
Article from late September…
forensic genealogy
$Qiagen NV (QGEN.US)$

Moomoo AI

Jan 8, 2024 22:29

Qiagen's high P/E ratio is worrisome due to its poor earnings forecast. Despite the high P/E, investors retain their shares, but this earnings growth rate may eventually impact the share price. The high P/E and future earnings predictions pose a substantial risk to shareholders and potential investors.

There's Reason For Concern Over Qiagen N.V.'s (NYSE:QGEN) Price

Moomoo AI

Dec 24, 2023 20:27

Qiagen's performance is strong due to strategic profit reinvestment, leading to significant earnings growth. Its respectable ROE contributes to a net income increase. Yet, forecasts anticipate a slowdown in future earnings growth.

Qiagen N.V.'s (NYSE:QGEN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

No comment yet